All articles by GlobalData Healthcare

Crenolanib delivers incremental benefit in FLT3/NPM1 co-mutated AML

Arog Pharmaceuticals presented new results from a Phase III trial at the American Society of Hematology (ASH) Annual Meeting 2025,…
ASH 2025: golcadomide + rituximab combo shows standout potential in R/R FL

Bristol Myers Squibb’s golcadomide, a first-in-class, oral CELMoD (cereblon E3 ligase modulator), has shown compelling activity as monotherapy and in…
Bipolar disorder market to reach $9.4bn across 7MM by 2034

The bipolar disorder (BD) market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and…
CKD-HPT, HP and HK market to reach $4bn across 7MM by 2034

The chronic kidney disease (CKD)-hyperparathyroidism (HPT), hyperphosphatemia (HP) and hyperkalemia (HK) market is poised to grow at a compound annual…
Physicians see growing role of real-world evidence in clinical trials and beyond

The use of real-world evidence (RWE) began gaining traction decades ago, primarily as a response to the limitation around traditional…

FDA awards record number of review designations to ADCs in 2024

Antibody drug conjugates (ADCs) have gained significant momentum in recent years, due to their clinical successes in cancer treatment. Since…
FDA inspection reveals critical supply chain vulnerabilities

When US Food and Drug Administration (FDA) inspectors arrived unannounced at Hetero Labs' warehouse facility in Visakhapatnam, India, on 19…
Real-time data: how to gain an edge amid clinical services consolidation

The pharmaceutical services industry is undergoing both innovation and consolidation – trends that are redefining competition and opening new strategic…
AHA 2025: Gene therapy shows potential in chronic heart failure

At the American Heart Association’s Scientific Sessions 2025 in New Orleans, results were discussed from a study demonstrating the potential…
AHA 2025: VANQUISH-2 Phase III VK2735 trial for overweight adults with T2D

At the 2025 American Heart Association (AHA) Scientific Sessions held in New Orleans, Louisiana, from 7 to 10 November 2025,…